Longitudinal patterns of drug injection behavior in the ALIVE Study cohort, 1988-2000: Description and determinants

American Journal of Epidemiology

Volumn 158, Issue 7, 2003, Pages 695-704

  Galai, Noya ^a,b   Safaeian, M ^a   Vlahov, D ^a,c   Bolotin, A ^b   Celentano, D D ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c NEW YORK ACADEMY OF MEDICINE   (United States)

Author keywords

Behavior; HIV; Longitudinal studies; Recurrence; Substance abuse, intravenous

Indexed keywords

DRUG USER;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; ANAMNESIS; ARTICLE; CONTROLLED STUDY; DOCTOR PATIENT RELATION; FEMALE; FOLLOW UP; HOMOSEXUALITY; HUMAN; INTRAVENOUS DRUG ABUSE; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; SELF REPORT; SEXUAL BEHAVIOR; SOCIAL BEHAVIOR; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGE OF ONSET; ALCOHOL DRINKING; BALTIMORE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; ODDS RATIO; PARENTS; PREVALENCE; PRISONERS; RECURRENCE; SEX DISTRIBUTION; SEXUAL BEHAVIOR; SMOKING; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0141732110     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwg209     Document Type: Article

References (26)

1. Joint United Nations Programme on HIV/AIDS. AIDS epidemic update-December 2002. Geneva, Switzerland: World Health Organization, 2002. (World Wide Web URL: http://www.who.int/hiv/pub/epidemiology/epi2002/en/).
2. Vaillant GE. Twelve-year follow-up of New York narcotic addicts. II. The natural history of a chronic disease. N Engl J Med 1966;275:1282-8.
3. Hser YI, Hoffman V, Grella CE, et al. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry 2001;58:503-8.
4. Schildhaus S, Gerstein D, Brittingham A, et al. Services Research Outcomes Study: overview of drug treatment population and outcomes. Subst Use Misuse 2000;35:1849-77.
5. Sheehan M, Oppenheimer E, Taylor C. Opiate users and the first years after treatment: outcome analysis of the proportion of follow up time spent in abstinence. Addiction 1993;88:1679-89.
6. Saxon AJ, Calsyn DA, Jackson TR. Longitudinal changes in injection behaviors in a cohort of injection drug users. Addiction 1994;89:191-202.
7. Lee SS, Hollinrake JB, Ng MH. Changing behavioral pattern of drug users in Hong Kong 1991-1995. Addiction 1998;93:541-8.
8. Thiede H, Hagan H, Murrill CS. Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area. J Urban Health 2000;77:331-45.
9. McCusker J, Stoddard AM, Hindin RN, et al. Changes in behavior following alternative residential programs of drug abuse treatment and AIDS education. Ann Epidemiol 1996;6:119-25.
10. Muga R, Tor J, Ginesta C, et al. Natural history of parenteral drug addicts treated in a general hospital. Br J Addict 1990;85:775-8.
11. Robertson JR, Ronald PJ, Raab GM, et al. Death, HIV infection, abstinence, and other outcomes in a cohort of injection drug users followed up for 10 years. BMJ 1994;309:369-72.
12. Morrison V. Starting, switching, stopping: users' explanations of illicit drug use. Drug Alcohol Depend 1991;27:213-17.
13. Van Ameijden EJ, Coutinho RA. Large decline in injecting drug use in Amsterdam, 1986-1998: explanatory mechanisms and determinants of injecting transitions. J Epidemiol Community Health 2001;55:356-63.
14. Des Jarlais DC, Perlis T, Friedman SR, et al. Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City 1990-1997. Am J Public Health 2000;90:1112-16.
15. Langendam MW, Van Brussel GH, Coutinho RA, et al. Methadone maintenance and cessation of injecting drug use: results from the Amsterdam Cohort Study. Addiction 2000;95:591-600.
16. Van Ameijden EJ, Van Den Hoek JA, Hartgers C, et al. Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users. Am J Epidemiol 1994;139:1153-63.
17. Celentano DD, Muñoz A, Cohn S, et al. Drug-related behavior change for H IV transmission among American injection drug users. Addiction 1994;89:1309-17.
18. Celentano DD, Muñoz A, Cohn S, et al. Dynamics of behavioral risk factors for HIV/AIDS: a 6-year prospective study of injection drug users. Drug Alcohol Depend 2001;61:315-22.
19. Vlahov D, Anthony JC, Muñoz A, et al. The ALIVE Study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr 1991;109:75-100.
20. Hser YI, Anglin MD, Grella C, et al. Drug treatment careers: a conceptual framework and existing research findings. J Subst Abuse Treat 1997;14:543-58.
21. Shah NG, Celentano DD, Vlahov D, et al. Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS 2000;14:2035-43.
22. MacGowan RJ, Brackbill RM, Rugg DL, et al. Sex, drugs and HIV counseling and testing: a prospective study of behavior-change among methadone-maintenance clients in New England. AIDS 1997;11:229-35.
23. Goldstein MF, Deren S, Beardsley M, et al. An alternative program for methadone maintenance dropouts: description and preliminary data. Mt Sinai J Med 2001;68:33-40.
24. Shore RE, Marmor M, Titus S, et al. Methadone maintenance and other factors associated with intraindividual temporal trends in injection-drug use. J Subst Abuse Treat 1996;13:241-8.
25. McLellan AT, Lewis DC, O'Brien CP, et al. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000;284:1689-95.
26. Taylor C. What happens in the long-term? Br Med Bull 1994;50:50-66.